A Pilot Study Evaluating the Synergistic Effect of Vedolizumab in Conjunction With Structured Semi-Vegetarian Diet on the Treatment of Ulcerative Colitis.
Withdrawn prior to enrolment
Phase of Trial: Phase 0
Latest Information Update: 05 Oct 2018
At a glance
- Drugs Vedolizumab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 24 Sep 2018 Status changed from not yet recruiting to withdrawn prior to enrolment as there were not enough patients to enroll.
- 20 Nov 2017 Planned End Date changed from 5 Jan 2018 to 31 Dec 2018.
- 20 Nov 2017 Planned primary completion date changed from 5 Jan 2018 to 31 Dec 2018.